Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 7/20 | 0.63 |
| ▸ | ITGB1 | P05556 | 6/20 | 0.54 |
| ▸ | ITGA5 | P08648 | 4/20 | 0.54 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.50 |
| ▸ | ITGAV | P06756 | 2/20 | 0.49 |
| ▸ | MMP2 | P08253 | 2/20 | 0.49 |
| ▸ | MMP9 | P14780 | 2/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5690691 | 0.96 | FKBP1A (0.56) | FKBP1AITGB1ITGA5ITGA4ITGAV | |
| SCHEMBL5690234 | 0.94 | FKBP1A (0.66) | FKBP1AITGB1ITGA5ITGA4ITGAV | |
| SCHEMBL5690857 | 0.91 | ITGB1 (0.56) | FKBP1AITGB1ITGA5ITGA4ITGAV | |
| SCHEMBL5690681 | 0.89 | ITGB1 (0.64) | FKBP1AITGB1ITGA5ITGA4ITGAV | |
| SCHEMBL5690603 | 0.88 | ITGA4 (0.57) | FKBP1AITGB1ITGA5ITGA4ITGAV | |
| SCHEMBL5690610 | 0.88 | ITGA4 (0.49) | FKBP1AITGB1ITGA5ITGA4ITGAV | |
| SCHEMBL5690662 | 0.87 | ITGA4 (0.53) | FKBP1AITGB1ITGA5ITGA4ITGAV | |
| SCHEMBL5690892 | 0.85 | ITGA4 (0.54) | FKBP1AITGB1ITGA5ITGA4ITGAV | |
| SCHEMBL5690625 | 0.85 | MAPK1 (0.66) | ITGB1ITGA5ITGA4ITGAVMAPK1 | |
| SCHEMBL5692072 | 0.85 | ITGB1 (0.56) | FKBP1AITGB1ITGA5ITGA4ITGAV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1001974-B1 | 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARM INC (US) | 2006-05-24 | — | — | EP | claimed |
| EP-1001974-A1 | 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | Elan Pharmaceuticals, Inc. (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1999006434-A1 | 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS INC. (US) | 1999-02-11 | — | — | WO | claimed |
| EP-1001974-B1 | 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARM INC (US) | 2006-05-24 | — | — | EP | disclosed |
| US-6291453-B1 | 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 | ATHENA NEUROSCIENCES, INC. | 2001-09-18 | — | — | US | disclosed |
| EP-1001974-A1 | 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | Elan Pharmaceuticals, Inc. (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999006434-A1 | 4-AMINO-PHENYLALANINE TYPE COMPOUNDS WHICH INHIBIT LEUKOCYTE ADHESION MEDIATED BY VLA-4 | ELAN PHARMACEUTICALS INC. (US) | 1999-02-11 | — | — | WO | disclosed |